{
  "CitationSubset": [
    "IM"
  ],
  "KeywordList": [
    [
      "Depression",
      "Multiple Sclerosis",
      "Quality of Life"
    ]
  ],
  "GeneralNote": [],
  "OtherAbstract": [],
  "SpaceFlightMission": [],
  "OtherID": [],
  "InvestigatorList": [],
  "PMID": "24403283",
  "DateCompleted": {
    "Year": "2014",
    "Month": "06",
    "Day": "20"
  },
  "DateRevised": {
    "Year": "2022",
    "Month": "12",
    "Day": "07"
  },
  "Article": {
    "ArticleDate": [
      {
        "Year": "2014",
        "Month": "01",
        "Day": "08"
      }
    ],
    "Language": [
      "eng"
    ],
    "ELocationID": [
      "10.1136/jnnp-2013-306829"
    ],
    "Journal": {
      "ISSN": "1468-330X",
      "JournalIssue": {
        "Volume": "85",
        "Issue": "6",
        "PubDate": {
          "Year": "2014",
          "Month": "Jun"
        }
      },
      "Title": "Journal of neurology, neurosurgery, and psychiatry",
      "ISOAbbreviation": "J Neurol Neurosurg Psychiatry"
    },
    "ArticleTitle": "Potential disease-modifying effects of selective serotonin reuptake inhibitors in multiple sclerosis: systematic review and meta-analysis.",
    "Pagination": {
      "StartPage": "709",
      "EndPage": "710",
      "MedlinePgn": "709-10"
    },
    "AuthorList": [
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Centre for Clinical Brain Sciences, University of Edinburgh, , Edinburgh, UK."
          }
        ],
        "LastName": "Foley",
        "ForeName": "P",
        "Initials": "P"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Lawler",
        "ForeName": "A",
        "Initials": "A"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Chandran",
        "ForeName": "S",
        "Initials": "S"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Mead",
        "ForeName": "G",
        "Initials": "G"
      }
    ],
    "PublicationTypeList": [
      "Letter",
      "Meta-Analysis",
      "Review",
      "Systematic Review"
    ]
  },
  "MedlineJournalInfo": {
    "Country": "England",
    "MedlineTA": "J Neurol Neurosurg Psychiatry",
    "NlmUniqueID": "2985191R",
    "ISSNLinking": "0022-3050"
  },
  "ChemicalList": [
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Antidepressive Agents"
    },
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Serotonin Uptake Inhibitors"
    }
  ],
  "MeshHeadingList": [
    {
      "QualifierName": [
        "therapeutic use"
      ],
      "DescriptorName": "Antidepressive Agents"
    },
    {
      "QualifierName": [
        "drug therapy",
        "etiology"
      ],
      "DescriptorName": "Depression"
    },
    {
      "QualifierName": [
        "drug therapy",
        "etiology"
      ],
      "DescriptorName": "Depressive Disorder, Major"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Humans"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Incidence"
    },
    {
      "QualifierName": [
        "psychology"
      ],
      "DescriptorName": "Multiple Sclerosis"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Randomized Controlled Trials as Topic"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Secondary Prevention"
    },
    {
      "QualifierName": [
        "therapeutic use"
      ],
      "DescriptorName": "Selective Serotonin Reuptake Inhibitors"
    }
  ]
}